Focus on long COVID

Approximately 30% of people who get COVID-19 develop long-term symptoms, or long COVID-19. Boy Anupong/Moment via Getty Images
How researchers are zeroing in on the self-targeted immune attacks that may lurk behind it, writes Matthew Woodruff, Emory University For almost three years, scientists have raced to understand the immune responses in patients who develop severe COVID-19, with an enormous effort aimed at defining where healthy immunity ends and destructive immunity begins. In the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous A new prescription
Next Pharmacists can play ‘key role’ in reducing overdose numbers